X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5302) 5302
Publication (532) 532
Newsletter (219) 219
Newspaper Article (50) 50
Book Review (47) 47
Book Chapter (23) 23
Book / eBook (13) 13
Dissertation (11) 11
Conference Proceeding (10) 10
Data Set (4) 4
Trade Publication Article (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4430) 4430
female (4092) 4092
cervical cancer (3089) 3089
index medicus (2879) 2879
human papillomavirus (2340) 2340
cancer (2212) 2212
adult (2205) 2205
papillomavirus infections (1691) 1691
oncology (1679) 1679
middle aged (1585) 1585
immunology (1499) 1499
uterine cervical neoplasms - virology (1392) 1392
women (1268) 1268
papillomavirus infections - virology (1019) 1019
cervical intraepithelial neoplasia (1009) 1009
health aspects (963) 963
uterine cervical neoplasms - pathology (900) 900
research (894) 894
risk factors (890) 890
adolescent (886) 886
infection (878) 878
infectious diseases (860) 860
aged (837) 837
uterine cervical neoplasms - immunology (837) 837
papillomavirus infections - prevention & control (831) 831
hpv (830) 830
intraepithelial neoplasia (810) 810
uterine cervical neoplasms - prevention & control (779) 779
vaccines (777) 777
prevalence (775) 775
vaccination (770) 770
cervical intraepithelial neoplasia - virology (740) 740
cervix (731) 731
papillomavirus infections - immunology (721) 721
papillomavirus infections - epidemiology (712) 712
young adult (710) 710
papillomaviridae - immunology (695) 695
papillomaviridae - genetics (688) 688
cervical-cancer (675) 675
papillomavirus infections - complications (657) 657
risk (656) 656
research article (629) 629
infections (628) 628
analysis (618) 618
diagnosis (615) 615
papillomaviruses (614) 614
male (612) 612
lesions (610) 610
prevention (594) 594
womens health (586) 586
uterine cervical neoplasms - epidemiology (585) 585
medicine (572) 572
virology (559) 559
dna (556) 556
papillomaviridae - isolation & purification (547) 547
papillomavirus vaccines - immunology (547) 547
uterine cervical neoplasms - diagnosis (528) 528
pathology (498) 498
animals (483) 483
young-women (482) 482
medical screening (479) 479
cervical intraepithelial neoplasia - pathology (476) 476
medicine, research & experimental (476) 476
multidisciplinary sciences (467) 467
epidemiology (463) 463
microbiology (447) 447
cytology (437) 437
science (436) 436
human-papillomavirus (431) 431
obstetrics & gynecology (427) 427
uterine cervical neoplasms - genetics (412) 412
polymerase chain reaction (407) 407
immunization (404) 404
papillomavirus infections - diagnosis (404) 404
neoplasia (403) 403
proteins (402) 402
deoxyribonucleic acid--dna (399) 399
expression (396) 396
human-papillomavirus infection (395) 395
genotype (393) 393
papillomavirus vaccines - administration & dosage (393) 393
carcinoma (391) 391
care and treatment (389) 389
cervical intraepithelial neoplasia - immunology (384) 384
genetic aspects (381) 381
development and progression (377) 377
natural-history (370) 370
virus diseases (368) 368
viruses (363) 363
allergy and immunology (360) 360
immunohistochemistry (358) 358
hiv (354) 354
virus-like particles (353) 353
medical research (348) 348
vaginal smears (346) 346
oncology, experimental (338) 338
article (337) 337
tumors (332) 332
particle vaccine (331) 331
human-papillomavirus type-16 (328) 328
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5530) 5530
French (22) 22
German (18) 18
Chinese (11) 11
Spanish (5) 5
Italian (4) 4
Japanese (4) 4
Polish (4) 4
Russian (4) 4
Serbian (2) 2
Swedish (2) 2
Ukrainian (2) 2
Arabic (1) 1
Croatian (1) 1
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Icelandic (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 140, Issue 2, pp. 245 - 252
Journal Article
Immunology, ISSN 0019-2805, 08/2013, Volume 139, Issue 4, pp. 513 - 522
Summary Impaired local cellular immunity contributes to the pathogenesis of persistent high‐risk human papillomavirus (HR‐HPV) infection and related cervical... 
programmed death‐1 | cytokines | cervical intraepithelial neoplasia | programmed death‐1 ligand | human papillomavirus | Programmed death-1 ligand | Human papillomavirus | Cytokines | Cervical intraepithelial neoplasia | Programmed death-1 | programmed death-1 ligand | DENDRITIC CELLS | IFN-GAMMA | CIN | HPV INFECTIONS | IMMUNOLOGY | CANCER | CD8 T-CELLS | RESPONSES | WOMEN | PATHWAY | programmed death-1 | UP-REGULATION | Up-Regulation | Cervical Intraepithelial Neoplasia - pathology | Dendritic Cells - immunology | Humans | Programmed Cell Death 1 Receptor - analysis | Uterine Cervical Neoplasms - pathology | Case-Control Studies | Papillomaviridae - genetics | T-Lymphocytes - virology | Papillomavirus Infections - pathology | Papillomaviridae - immunology | Flow Cytometry | Papillomavirus Infections - immunology | Adult | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - immunology | Dendritic Cells - virology | Interleukin-10 - analysis | Interleukin-12 - analysis | B7-1 Antigen - analysis | Enzyme-Linked Immunosorbent Assay | Uterine Cervical Neoplasms - immunology | B7-2 Antigen - analysis | Cervical Intraepithelial Neoplasia - virology | Exudates and Transudates - immunology | Papillomaviridae - pathogenicity | Interferon-gamma - analysis | Biopsy | Uterine Cervical Neoplasms - virology | T-Lymphocytes - immunology | B7-H1 Antigen - analysis | Human Papillomavirus DNA Tests | Neoplasm Staging | Immunity, Cellular | Papillomaviruses | Cervix dysplasia | Development and progression | Disease susceptibility | Biological response modifiers | T cells | Papillomavirus infections | Ligands | Cervical cancer | Original
Journal Article
International Journal of Cancer, ISSN 0020-7136, 04/2016, Volume 138, Issue 7, pp. 1732 - 1740
Journal Article
Vaccine, ISSN 0264-410X, 2004, Volume 23, Issue 2, pp. 172 - 181
: Persistent infection of cervical epithelium with “high risk” human papillomavirus (HPV) results in cervical intraepithelial neoplasia (CIN) from which... 
Human papillomavirus | Delayed type hypersensitivity | Immunotherapy | Cervical intraepithelial neoplasia | Cellular immunity | Viral load | Cervical cancer | REGRESSION | MEDICINE, RESEARCH & EXPERIMENTAL | DESIGN | cellular immunity | VACCINE | HUMAN-PAPILLOMAVIRUS | IMMUNOLOGY | cervical cancer | cervical intraepithelial neoplasia | delayed type hypersensitivity | HPV | viral load | IMMUNE-RESPONSES | immunotherapy | human papillomavirus | Recombinant Fusion Proteins - immunology | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Papillomavirus E7 Proteins | Papillomavirus Infections - therapy | Uterine Cervical Dysplasia - immunology | Cancer Vaccines - therapeutic use | Papillomaviridae - immunology | Cervical Intraepithelial Neoplasia - therapy | Uterine Cervical Dysplasia - virology | Papillomavirus Infections - immunology | Adult | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Saponins - therapeutic use | Cervical Intraepithelial Neoplasia - immunology | Phospholipids - therapeutic use | Uterine Cervical Dysplasia - therapy | Adjuvants, Immunologic | Repressor Proteins - genetics | Cervical Intraepithelial Neoplasia - virology | Cancer Vaccines - immunology | Adolescent | Cholesterol - therapeutic use | Drug Combinations | Proteins | Lymphocytes | Laboratories | Infections | Histology | Vaccines | Patients
Journal Article
Science translational medicine, ISSN 1946-6234, 2014, Volume 6, Issue 221, pp. 221ra13 - 221ra13
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2006, Volume 105, Issue 1, pp. 157 - 165
Journal Article
Journal of Immunology, ISSN 0022-1767, 12/2010, Volume 185, Issue 11, pp. 7107 - 7114
Journal Article
International Journal of Cancer, ISSN 0020-7136, 12/2007, Volume 121, Issue 12, pp. 2794 - 2800
Persistent infection with human papillomaviruses (HPV) is a prerequisite for the development of cervical cancer. Vaccination with virus‐like particles (VLP)... 
clinical trial | antibody | cervical cancer | immunization | T cell | Clinical trial | Immunization | Antibody | Cervical cancer | IMMUNE-RESPONSE | HUMAN-PAPILLOMAVIRUS TYPE-16 | PERSISTENCE | PREVALENCE | CANCER | ONCOLOGY | IMMUNOTHERAPY | INFECTION | GLUTATHIONE-S-TRANSFERASE | YOUNG-WOMEN | T-CELLS | Oncogene Proteins, Fusion - therapeutic use | Oncogene Proteins, Viral - administration & dosage | Cervical Intraepithelial Neoplasia - pathology | Humans | Middle Aged | Oncogene Proteins, Fusion - adverse effects | DNA, Viral - isolation & purification | Cervical Intraepithelial Neoplasia - drug therapy | Uterine Cervical Neoplasms - pathology | Human papillomavirus 16 - immunology | Cancer Vaccines - therapeutic use | Human papillomavirus 16 - isolation & purification | Time Factors | Tumor Virus Infections - immunology | Papillomavirus Infections - immunology | Papillomavirus Vaccines - adverse effects | Adult | Female | Cervical Intraepithelial Neoplasia - immunology | Papillomavirus Vaccines - administration & dosage | DNA, Viral - drug effects | Oncogene Proteins, Viral - adverse effects | Papillomavirus Infections - complications | Papillomavirus Vaccines - therapeutic use | Double-Blind Method | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Uterine Cervical Neoplasms - immunology | Cancer Vaccines - adverse effects | Oncogene Proteins, Viral - therapeutic use | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Oncogene Proteins, Fusion - administration & dosage | Tumor Virus Infections - drug therapy | Cervical Intraepithelial Neoplasia - virology | Tumor Virus Infections - complications | Papillomavirus Infections - drug therapy | Uterine Cervical Neoplasms - virology | Aged | Human papillomavirus 16 - genetics
Journal Article
British Journal of Cancer, ISSN 0007-0920, 06/2011, Volume 105, Issue 1, pp. 28 - 37
Journal Article
Cancer Science, ISSN 1347-9032, 06/2009, Volume 100, Issue 6, pp. 1112 - 1117
Regulatory (FOXP3+) T cells (Tregs) comprise a subpopulation of CD4+ T cells that suppress autoreactive immune cells, thereby protecting organs and tissues... 
HIGH-GRADE | DENDRITIC CELLS | TUMOR REJECTION | ONCOLOGY | IN-VIVO | VACCINE | FUSION PROTEIN | DEPLETION | PERIPHERAL-BLOOD | ANTITUMOR IMMUNITY | OVARIAN-CANCER | Cervical Intraepithelial Neoplasia - pathology | Immunotherapy - methods | Receptors, Nerve Growth Factor - immunology | Humans | Antibodies, Monoclonal - therapeutic use | Transplantation, Heterologous | Uterine Cervical Neoplasms - pathology | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Antigens, CD - analysis | CD4-Positive T-Lymphocytes - immunology | DNA Methylation | Papillomavirus Infections - immunology | Female | Cervical Intraepithelial Neoplasia - immunology | Papillomavirus Infections - complications | Glucocorticoid-Induced TNFR-Related Protein | Uterine Cervical Neoplasms - immunology | Uterine Cervical Neoplasms - genetics | CD3 Complex - analysis | Animals | Lymphocytes, Tumor-Infiltrating - pathology | Forkhead Transcription Factors - analysis | T-Lymphocytes - immunology | Cervical Intraepithelial Neoplasia - genetics | Mice | CD8-Positive T-Lymphocytes - immunology | Receptors, Tumor Necrosis Factor - immunology | Lymphocytes, Tumor-Infiltrating - immunology | Autoimmunity | Care and treatment | Cervix dysplasia | Oncology, Experimental | Vaccination | Melanoma | Research | T cells | Colon cancer | Health aspects | Cervical cancer | Tumors | Cancer
Journal Article